Nachrichten - Pressemitteilungen

    Shire plc announced today that the U.S. Food and Drug Administration (FDA) approved Vyvanse(R) (lisdexamfetamine dimesylate) Capsules (CII), the first and only medication for the treatment of moderate to severe binge eating disorder (B.E.D.) in …

    Themen: CapUSASom

    LEXINGTON, Massachusetts, January 30, 2015 /PRNewswire/ - Shire plc (LSE: SHP, NASDAQ: SHPG) announced today that the U.S. Food and Drug Administration (FDA) approved Vyvanse® (lisdexamfetamine dimesylate) Capsules (CII), the first and only …

    Wertpapier: Shire Sp ADR

    Themen: CapNASDAQSom
    ZeitTitel
    00:00 
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.

    Weitere Nachrichten Pressemitteilungen

    TitelLeser
    338
    327
    326
    272
    265
    260
    259
    258
    257
    253
    TitelLeser
    2250
    1630
    1468
    758
    675
    576
    560
    554
    551
    509
    TitelLeser
    3461
    2997
    2250
    1866
    1630
    1593
    1468
    1392
    1349
    1332
    TitelLeser
    88605
    18041
    17228
    14737
    13551
    11261
    10463
    10344
    10112
    9961